Victor Sandor

Insider Reports History

Entity: Individual
Location: C/O Array Biopharma Inc., 3200 Walnut Street, Boulder, CO
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
ADC Therapeutics SA	Director	Common Shares	80.9K	$234K	$2.89	Jun 17, 2024	Direct
Merus N.V.	Director	Share Option (right to buy)	8.84K	$120K	$13.52	May 7, 2024	Direct
Prelude Therapeutics Inc	Director	Director Stock Option (Right to Buy)	23.5K			Jun 14, 2024	Direct
Kymera Therapeutics, Inc.	Director	Stock Option (Right to Buy)	16K			Jun 18, 2024	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
KYMR	Kymera Therapeutics, Inc.	Jun 18, 2024	1	$0	4	Jun 20, 2024	Director
ADCT	ADC Therapeutics SA	Jun 17, 2024	1	-$20.2K	4	Jun 18, 2024	Director
PRLD	Prelude Therapeutics Inc	Jun 14, 2024	1	$0	4	Jun 18, 2024	Director
ADCT	ADC Therapeutics SA	Jun 13, 2024	1	$0	4	Jun 14, 2024	Director
MRUS	Merus N.V.	May 7, 2024	1	$0	4	May 9, 2024	Director
ADCT	ADC Therapeutics SA	Jan 2, 2024	0	$0	3	Jan 2, 2024	Director
PRLD	Prelude Therapeutics Inc	Jun 16, 2023	1	$0	4	Jun 21, 2023	Director
KYMR	Kymera Therapeutics, Inc.	Jun 15, 2023	1	$0	4	Jun 20, 2023	Director
MRUS	Merus N.V.	Jun 8, 2023	1	$0	4	Jun 12, 2023	Director
KYMR	Kymera Therapeutics, Inc.	Nov 3, 2022	1	$0	4	Nov 3, 2022	Director
KYMR	Kymera Therapeutics, Inc.	Nov 3, 2022	0	$0	3	Nov 3, 2022	Director
PRLD	Prelude Therapeutics Inc	Jun 17, 2022	1	$0	4	Jun 22, 2022	Director
MRUS	Merus N.V.	May 31, 2022	1	$0	4	Jun 2, 2022	Director
PRLD	Prelude Therapeutics Inc	Jan 3, 2022	1	$0	4	Jan 5, 2022	Director
PRLD	Prelude Therapeutics Inc	Oct 13, 2021	1	$0	4	Oct 14, 2021	Director
PRLD	Prelude Therapeutics Inc	Jun 18, 2021	1	$0	4	Jun 22, 2021	Director
MRUS	Merus N.V.	May 28, 2021	1	$0	4	Jun 2, 2021	Director